13F-HR filed by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 217 holding rows worth $1,064,573,342.
- Accession
- 0001940272-25-000008
- Filer
- CIK 1940272
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 220 entries on the cover page, a total value of $1,064,573,342 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,064,573,342 with VALUE read as dollars as filed, 13F file number 028-23931. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,350,826 | $114,685,127 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 5,389,264 | $85,258,156 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 989,182 | $65,711,360 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,347,501 | $50,647,690 | dollars as filed | |
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 337,125 | $38,385,053 | dollars as filed | |
| SPY | 78462F103 | SHS | 54,684 | $36,429,387 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,241,753 | $36,137,058 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 2,113,153 | $31,063,349 | dollars as filed | |
| SPY | 78462F103 | SHS | 45,500 | $30,311,190 | dollars as filed | put |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 868,780 | $29,442,954 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 518,921 | $28,519,898 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 1,176,491 | $22,129,796 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,469,098 | $14,338,396 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 273,414 | $14,201,123 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 2,903,226 | $13,180,646 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 507,771 | $13,095,414 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 4,045,414 | $12,904,871 | dollars as filed | |
| SPDR Bloomberg 1-3 Month T-Bill ETF | 78468R663 | SHS | 135,585 | $12,439,924 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 866,202 | $11,771,685 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 200,000 | $11,674,000 | dollars as filed | call |
| BIOAGE LABS INC COM | 09077V100 | Stock | 1,880,073 | $11,054,829 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 129,999 | $10,617,018 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 248,368 | $10,344,527 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 1,531,953 | $10,172,168 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 248,917 | $10,026,377 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,835,680 | $9,272,674 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 15,700 | $8,827,639 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 133,818 | $8,754,374 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 351,032 | $8,579,222 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 5,247,603 | $8,501,117 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 7,370,987 | $8,108,086 | dollars as filed | |
| METSERA INC | 59267L107 | COM | 152,521 | $7,981,424 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 5,559,988 | $7,950,783 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 750,000 | $7,920,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 133,316 | $7,781,655 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 213,064 | $7,674,565 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 815,975 | $7,670,165 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 189,098 | $7,592,285 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 36,345 | $7,225,749 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,988,288 | $7,098,188 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 349,807 | $6,740,781 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 139,136 | $6,497,651 | dollars as filed | |
| AA MISSION ACQUISITION CORP | G1000R101 | ORD SHS CL A | 578,359 | $6,084,337 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 501,228 | $5,804,220 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 51,450 | $5,490,230 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 516,482 | $5,479,874 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 267,816 | $5,409,883 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 49,571 | $5,006,175 | dollars as filed | |
| ATAIBECKLEY INC | N0731H103 | Equity | 913,242 | $4,831,050 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 11,200 | $4,695,152 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 175,919 | $4,623,151 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 45,000 | $4,447,125 | dollars as filed | principal |
| AA MISSION ACQUISITION CORP | G1000R101 | ORD SHS CL A | 405,089 | $4,261,536 | dollars as filed | call |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 978,894 | $4,101,566 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 72,007 | $4,097,198 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 40,000 | $4,008,000 | dollars as filed | put |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 90,688 | $3,717,301 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 74,212 | $3,502,806 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 18,523 | $3,269,865 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 114,359 | $3,252,370 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 341,612 | $3,142,830 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 33,313 | $3,136,419 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 78,238 | $2,966,785 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 75,187 | $2,919,511 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 109,442 | $2,831,265 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 652,154 | $2,823,827 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 20,000 | $2,811,500 | dollars as filed | principal |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 7,000 | $2,741,480 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 31,484 | $2,584,836 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 18,000 | $2,521,440 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 224,385 | $2,412,139 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 53,656 | $2,337,792 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 4,895 | $2,245,141 | dollars as filed | |
| A SPAC III ACQUISITION CORP | G0544A103 | ORD SHS CL A | 215,000 | $2,223,100 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 15,000 | $2,213,250 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 101,704 | $2,194,772 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 102,969 | $2,127,340 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 21,522 | $2,060,947 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 205,409 | $1,982,197 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 40,235 | $1,926,854 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 575,800 | $1,877,108 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 1,090,628 | $1,745,005 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 49,800 | $1,717,602 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 25,230 | $1,705,548 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 170,000 | $1,688,100 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 56,200 | $1,686,000 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 215,752 | $1,598,722 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 18,540 | $1,556,062 | dollars as filed | |
| Cohen Circle Acquisit Corp I Unit 07/01/2030 | G2254C105 | Unit | 150,000 | $1,542,000 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 891,183 | $1,523,923 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 128,865 | $1,511,586 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 37,000 | $1,485,180 | dollars as filed | |
| WW INTL INC | 98262P200 | COM NEW | 52,450 | $1,435,032 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 193,934 | $1,411,840 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 53,666 | $1,301,401 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 775,034 | $1,263,305 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 44,400 | $1,131,312 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 151,495 | $1,086,219 | dollars as filed | |
| GRACE THERAPEUTICS INC | 00439U104 | COM | 350,450 | $1,043,290 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 11,842 | $1,024,096 | dollars as filed | |
| BEST SPAC I ACQUISITION CORP | G1069P137 | UNIT 05/27/2030 | 100,000 | $1,016,000 | dollars as filed | |
| ELECTRONIC ARTS INC COM | 285512109 | Stock | 4,936 | $995,591 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 10,000 | $986,200 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 77,961 | $916,042 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 197,615 | $889,268 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 56,007 | $878,750 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 119,067 | $871,570 | dollars as filed | |
| KEEN VISION ACQUISITION CORP | G52443119 | SHS | 75,000 | $863,258 | dollars as filed | call |
| PHARVARIS NV | N69605108 | COMMON STOCK | 34,124 | $851,394 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 40,000 | $798,000 | dollars as filed | call |
| Eli Lilly and Company | 532457108 | COM | 1,000 | $763,000 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 235,689 | $761,275 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 20,087 | $748,040 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 51,516 | $748,012 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 373,682 | $709,996 | dollars as filed | |
| LITE STRATEGY INC | 55279B301 | COM | 292,397 | $707,601 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 82,591 | $703,675 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 35,000 | $698,250 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 75,000 | $690,000 | dollars as filed | call |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 14,418 | $689,036 | dollars as filed | |
| CERIDIAN HCM HLDG INC | 15677J108 | COM | 10,000 | $688,900 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 26,045 | $675,347 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 40,000 | $648,800 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 3,578 | $639,496 | dollars as filed | |
| GERON CORP | 374163103 | COM | 456,176 | $624,961 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 59,230 | $595,262 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 34,051 | $570,695 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 212,531 | $558,957 | dollars as filed | |
| AMERICAN EXCEPTIONALISM ACQU | G0273J101 | ORD CL A | 50,000 | $546,500 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 20,000 | $544,200 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 11,619 | $541,213 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 30,633 | $530,870 | dollars as filed | |
| BRIGHTHOUSE FINL INC | 10922N103 | COM | 10,000 | $530,800 | dollars as filed | |
| Globa Terra Acquisition Cor Unit 99/99/9999 | G3933N108 | Unit | 50,000 | $508,500 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 42,900 | $504,933 | dollars as filed | |
| WISDOMTREE TR | 97717Y527 | FLOATNG RAT TREA | 10,000 | $502,700 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 124,967 | $487,371 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 55,000 | $486,750 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 18,947 | $485,043 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 37,663 | $476,437 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 167,941 | $466,876 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 20,000 | $452,600 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 6,000 | $445,200 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 34,000 | $439,280 | dollars as filed | |
| INTELLIGENT BIO SOLUTIONS IN | 36151G600 | COM | 426,433 | $434,962 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 20,000 | $432,800 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 15,200 | $425,600 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 32,393 | $411,715 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 53,428 | $406,587 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 113,062 | $401,370 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 20,840 | $400,753 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 30,000 | $387,600 | dollars as filed | call |
| BIOHAVEN LTD | G1110E107 | COM | 25,000 | $375,250 | dollars as filed | call |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 6,000 | $374,880 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 24,341 | $365,358 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 36,200 | $354,398 | dollars as filed | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 10,000 | $349,800 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 214,497 | $347,485 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 351,094 | $340,140 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 2,500 | $329,500 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 25,000 | $312,000 | dollars as filed | |
| AGRICULTURE & NAT SOL ACQ CO | G0131Y100 | SHS CL A | 27,062 | $295,517 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 6,143 | $291,670 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 31,200 | $288,288 | dollars as filed | |
| PROCAP ACQUISITION CORP | G7257A113 | UNIT 05/16/2030 | 26,940 | $282,870 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 10,245 | $282,352 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 9,000 | $270,720 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 133,530 | $268,395 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 4,900 | $265,384 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 81,600 | $253,776 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 20,000 | $253,000 | dollars as filed | call |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 25,000 | $244,750 | dollars as filed | call |
| ALUMIS INC | 022307102 | COM | 61,291 | $244,551 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 81,000 | $235,710 | dollars as filed | |
| THERAPEUTICSMD INC | 88338N206 | COM NEW | 209,210 | $224,901 | dollars as filed | |
| KALA BIO INC | 483119202 | COM NEW | 141,995 | $217,252 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 115,539 | $217,213 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 13,705 | $216,402 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 159,479 | $213,702 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 50,000 | $209,500 | dollars as filed | call |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 28,023 | $197,562 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 33,278 | $196,007 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 50,000 | $175,000 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 35,000 | $170,800 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 36,842 | $170,210 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 25,000 | $163,500 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 35,000 | $163,450 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 222,500 | $160,512 | dollars as filed | put |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 35,223 | $153,220 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 47,800 | $150,570 | dollars as filed | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 48,300 | $147,798 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 16,712 | $145,227 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 55,100 | $144,913 | dollars as filed | call |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 101,008 | $141,411 | dollars as filed | |
| GENERATION BIO CO | 37148K209 | COM NEW | 22,144 | $135,521 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 10,200 | $129,030 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 175,000 | $126,245 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 17,000 | $121,890 | dollars as filed | call |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 10,000 | $121,800 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 50,000 | $108,500 | dollars as filed | call |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 10,000 | $106,800 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 18,643 | $96,757 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 50,000 | $75,500 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 10,000 | $75,100 | dollars as filed | |
| SOLIDION TECHNOLOGY INC | 834212201 | COM NEW | 13,500 | $62,640 | dollars as filed | call |
| ATYR PHARMA INC | 002120202 | COM NEW | 84,800 | $61,175 | dollars as filed | call |
| A SPAC III ACQUISITION CORP | G0544A145 | RIGHT 01/02/2026 | 215,000 | $40,979 | dollars as filed | |
| BIOMX INC | 09090D301 | COM | 77,656 | $40,769 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 15,000 | $30,150 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 12,406 | $26,115 | dollars as filed | |
| MURAL ONCOLOGY PUB LTD CO | G63365103 | ORD SHS | 11,855 | $24,540 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 27,000 | $22,351 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 10,000 | $21,300 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 13,097 | $20,824 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 10,366 | $17,000 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 12,846 | $16,700 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 25,830 | $11,727 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001940272-25-000008 | this filing | 2025-11-14 | acceptance time not in the bulk data set |